Trial intelligence / Profile preview

Ketamine and Hydromorphone PCA for Pediatric Mucositis

NCT00474110Phase 3Withdrawn

Sponsor
University of British Columbia
Start
Aug 2009
Primary completion
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ketamine in oral mucositis (OM), sponsored by University of British Columbia. Planned start Aug 2009; status: withdrawn.

02

Drugs

ketamine
03

Conditions

oral mucositis (OM)

Beyond the preview

Go deeper on NCT00474110.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00474110.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call